12:00 AM
Mar 26, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

JVS-100: Phase II start

Next quarter, Juventas will begin a Phase II trial to evaluate JVS-100 delivered with the Helical Infusion System from BioCardia Inc. (San Carlos, Calif.) in...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >